Abstracts tagged "Myositis and scleroderma"

Abstract Number: 948 • 2017 ACR/ARHP Annual Meeting
Application of a Diagnostic Algorithm to Identify Inflammatory Myopathy in Systemic Sclerosis
Vandana Bhushan^1,2, Adam Maundrell¹, Charlotte Proudman^1,2, Leah McWilliams¹, Llew Spargo¹, Robert Metcalf¹, Jennifer Walker³, Mandana Nikpour^4,5, Wendy Stevens⁴, Vidya Limaye^1,2 and Susanna Proudman^1,2, ¹Rheumatology Unit, Royal Adelaide Hospital, South Australia, Adelaide, Australia, ²Discipline of Medicine, University of Adelaide, South Australia, Adelaide, Australia, ³Flinders University of South Australia, Adelaide, Australia, ⁴St Vincent's Hospital, Melbourne, Victoria, Melbourne, Australia, ⁵Department of Medicine, University of Melbourne, Victoria, Melbourne, Australia
Background/Purpose: Muscle involvement in systemic sclerosis (SSc) is under-recognised and poorly understood. Reported prevalence varies up to 15%, reflecting lack of consistent definition, the heterogeneous…
Abstract Number: 205 • 2012 ACR/ARHP Annual Meeting
Idiopathic Inflammatory Myositis Is Associated with an Increased Incidence of Systemic Sclerosis
Shreyas H. Chaudhary¹, Susanna Proudman² and Vidya S. Limaye³, ¹Medical Student University of Adelaide, Adelaide, Australia, ²Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, ³Royal Adelaide Hospital, Adelaide, Australia
Background/Purpose: Systemic sclerosis (SSc) and idiopathic inflammatory myositis (IIM) are two systemic autoimmune connective tissue diseases with predominant effects on skin and muscle respectively .…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].